The guidelines emphasize that staging laparoscopy should not be considered a routine procedural formality but rather a decision-altering investigation capable of preventing non-therapeutic laparotomy and inappropriate radical surgery. The recommendations also integrate modern perioperative treatment pathways centered on FLOT chemotherapy, while emerging evidence supports the addition of immunotherapy agents such as durvalumab in selected patients. Management of advanced disease is increasingly guided by molecular profiling, including HER2, Claudin 18.2, PD-L1 expression, and MSI/dMMR status.
For laparoscopic gastric cancer surgeons, operative staging is becoming increasingly integrated with personalized oncology. The ability to identify occult peritoneal disease before major gastrectomy remains one of the most valuable contributions of minimally invasive surgery in gastric cancer management.
Source: PubMed Study
A major study published in Annals of Surgical Oncology analyzed 653 patients with apparently non-metastatic locally advanced gastric or gastroesophageal junction adenocarcinoma who underwent staging laparoscopy and peritoneal lavage cytology.
The findings were striking:
Occult peritoneal metastases were identified in 22.2% of patients.
Younger patients (<35 years), gastric primary tumors, elevated CA72-4, T4 disease, and even minimal ascites were associated with increased risk.
Repeat laparoscopy after systemic therapy altered metastatic status in 26.4% of re-explored patients.
Patients converting from positive to negative peritoneal status experienced improved survival, while conversion to positive disease identified a subgroup with significantly worse prognosis.
The study strongly supports routine staging laparoscopy and lavage cytology in locally advanced gastric cancer and highlights the emerging value of repeat laparoscopy following neoadjuvant treatment when operative intent may change based on treatment response.
Source: PubMed Study
A Journal of Surgical Oncology investigation explored the use of methylated DNA biomarkers in peritoneal lavage fluid obtained during staging laparoscopy for radiographically localized pancreatic ductal adenocarcinoma.
Among 48 patients evaluated:
Fifteen had occult intra-abdominal metastatic disease.
Methylated DNA markers achieved 87% sensitivity and 90% specificity.
Diagnostic performance reached an impressive AUC of 0.98.
By comparison, KRAS mutation testing demonstrated substantially lower sensitivity.
Traditional cytology frequently misses microscopic peritoneal disease. If validated in larger prospective studies, molecular lavage analysis could transform staging laparoscopy from a purely visual procedure into a biologic staging platform capable of identifying patients unlikely to benefit from major pancreatic resection.
Source: PubMed Study
Right Gastric Artery Preservation Reduced Early Anastomotic Stricture Following Minimally Invasive McKeown Esophagectomy
A randomized trial published in Diseases of the Esophagus compared preservation versus ligation of the right gastric artery during totally minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma.
The investigators reported:
Early cervical anastomotic stenosis occurred in 30% of patients with artery preservation versus 60% after ligation.
Fewer postoperative endoscopic dilatations were required.
Leak rates were numerically lower.
Lymph node harvest remained equivalent.
No conversions occurred.
The benefit appeared most pronounced during the early postoperative period when conduit perfusion is critical.
This study provides a practical technical modification that may reduce postoperative dysphagia and the need for repeated endoscopic interventions without compromising oncologic radicality.
Source: PubMed Study
A retrospective study involving 224 patients undergoing laparoscopic or robotic colorectal resections examined the addition of quadratus lumborum (QL) block to standard enhanced recovery pathways.
Although immediate postoperative opioid requirements were similar, patients receiving combined TAP and QL blocks demonstrated:
Reduced opioid consumption by postoperative day two.
Lower pain scores.
Earlier bowel function recovery.
Shorter hospital stay.
The authors acknowledge limitations related to retrospective design and institutional practice variability.
Effective pain control remains a cornerstone of Enhanced Recovery After Surgery (ERAS) programs. QL blocks may provide meaningful benefits in postoperative recovery, mobilization, and gastrointestinal function after minimally invasive colorectal procedures.
Source: PubMed Study
Today's evidence highlights the expanding role of staging laparoscopy beyond simple visual inspection. From gastric cancer and pancreatic cancer to advanced molecular peritoneal assessment, minimally invasive staging continues to evolve into a powerful decision-making tool that influences treatment selection, resectability assessment, and long-term outcomes. At the same time, technical refinements such as right gastric artery preservation and optimized regional anesthesia demonstrate how small operative modifications can significantly improve postoperative recovery and patient quality of life.